Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

First patient treated in Hansa Medical’s Highdes-study

Hansa Medical AB (publ) today announced that the first patient has been treated and subsequently transplanted in the pivotal multicenter study Highdes using IdeS to desensitize highly sensitized patients prior to kidney transplantation.The Phase II study will include approximately 20 highly sensitized patients awaiting kidney transplantation. Patients included in this new study have either failed on previous attempts of desensitization or the currently available methods are considered insufficiently effective. The study is entitled “A Phase II Study to Evaluate the Efficacy of IdeS (IgG

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 4 635 treasury shares on 30 September 2016. The shares were purchased at an average price of NOK 40.00. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 519 277 treasury shares. Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at

Orkla ASA: Mandatory notification of trade - options

On 30 September, in connection with Orkla's former management option programme, 15,000 options in Orkla-shares were exercised at a strike price of NOK 40.03 per share. After this transaction, the total number of options issued in Orkla shares under the management option programme is 1,045,000. Orkla owns 1,303,135 treasury shares.Orkla ASAOslo, 3 October 2016Ref.:Investor RelationsElise HeidenreichTel.: +47 951 41 147 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Hexagon Composites ASA: Closing of the Agility Fuel Solutions transaction

Reference is made to stock exchange release dated 14 June 2016 related to the announced merger of Agility Fuel Systems and Hexagon Composites to create Agility Fuel Solutions. The closing of the transaction was completed on 3 October.The new entity Agility Fuel Solutions is owned equally by Hexagon Composites and Agility's current investors and will continue to transform the global medium- and heavy-duty vehicle industry with clean fuel technologies. As of fourth quarter 2016 the entity will be reported under the equity method in the Group's financial statements.For more information:

Aker BP ASA: Acquisition of licenses from Tullow

Aker BP ASA (“Aker BP” or “the Company”) announces the acquisition of licenses from Tullow Norge AS (“Tullow”). The transaction comprises working interest in eight licenses, including 15 percent in the Oda (previously known as Butch) discovery in PL 405.The transaction strengthens Aker BP’s position in core areas surrounding the Ula, North of Alvheim, Skarv and the Krafla/Askja areas. The Oda development concept is a tie-in to the Ula field and the discovery is estimated to contain 43 million (gross) barrels of oil equivalent (Source: NPD). The partners are targeting an investment

More than half of persons with Alzheimer’s disease aged 90 years or more use psychotropic drugs

Psychotropic drug use is rather common among persons aged 90 years of more diagnosed with Alzheimer’s disease compared with those who were diagnosed at younger age, concludes study conducted at University of Eastern Finland. Persons aged 90 years or more used antipsychotics 5 times and antidepressants 2.5 times more often than those without the disease in the same age group. The results were published in Age and Ageing journal. 56% of persons aged 90 years or more with Alzheimer’s disease use psychotropic drugs whereas the same figure was 48% among younger persons with Alzheimer’s

Herlev Hospital in Denmark has ordered a VibroSense Meter system

The department of Clinical Neurophysiology and Nuclear Medicine at the Herlev Hospital in Denmark has ordered a VibroSense Meter device for assessment of impaired sensitivity in hands. The order is regarded as a prestige order and the order value exceeds SEK 160 000.The CE approved VibroSense Meter device, will be used for research in different areas to diagnose neurological disorders in hands caused by various diseases. This order is regarded as a prestigious order, since researchers are particularly important in order to reach a large market. The reason is that scientists are important

BLACKSTONE UPDATES ITS PROPOSAL FOR ELECTION OF BOARD MEMBERS AHEAD OF EXTRAORDINARY GENERAL MEETING IN D. CARNEGIE & CO AB (PUBL) ON 14 OCTOBER 2016

D. Carnegie & Co AB (publ) (“D. Carnegie & Co” or the “Company”) has been informed by Vega Holdco Sarl (“Vega”), controlled by Blackstone and holder of approximately 28.61 percent of the total number of outstanding shares in the Company, that Vega wishes to update its proposal to the extraordinary general meeting on 14 October 2016 regarding the election of board members. The updated proposal entails that James Seppala replaces Andrew Lax as proposed board member and chairman of the board. Svein Erik Lilleland remains the second proposed board member and no other changes are made to Vega’s

ASTRAZENECA PLC ANNOUNCES MEDIMMUNE OUT-LICENSES POTENTIAL MEDICINE FOR INFLAMMATORY DISEASES TO ALLERGAN

This announcement contains inside information 03 October 2016 07:00   AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing agreement with Allergan plc for the global rights to MEDI2070. MEDI2070 is an IL-23 monoclonal antibody currently in a Phase IIb clinical trial for moderate-to-severe Crohn's disease (a chronic inflammatory disease of the intestines) and is ready for Phase II for ulcerative colitis (a chronic inflammatory condition of the colon and rectum). These diseases are outside AstraZeneca's three main

DDM Treasury Sweden AB redeems its 18% subordinated notes

DDM Treasury Sweden AB (NGM: DDM1), a specialist investor in and manager of non-performing loans and distressed assets, announces that it has fully redeemed its SEK 31M 18% subordinated notes on their final maturity date of 30 September 2016.The redemption was financed using cash on hand. This transaction has enabled DDM Treasury Sweden AB to reduce its gross debt and its cost of debt. Roschier acted as DDM’s legal advisors in conjunction with the redemption of the subordinated notes. This information is information which DDM Treasury Sweden AB (publ) AG is obliged to make public

DDM makes significant loan repayments in excess of EUR 8M, including the redemption of its 18% subordinated notes

DDM Holding AG (First North: DDM), a specialist investor in and manager of non-performing loans and distressed assets, announces that it has made significant loan repayments in excess of EUR 8M during the third quarter of 2016.The loan repayments include the full redemption of the SEK 31M 18% subordinated notes issued by DDM Treasury Sweden AB on their final maturity date of 30 September 2016. In addition, repayments of about EUR 3M were made on the EUR 11M bond issued in July 2016, following strong performance by the recently acquired Slovenian portfolio. Additionally, EUR 2M out of the

NICOCCINO’S NICOTINE PATENT NOW ACCEPTED IN NEW ZEALAND

The New Zealand’s Intellectual Property Office has notified Nicoccino AB with the acceptance of the Company’s own nicotine patent application. The approval was published on September 30thand a three months Opposition Period will follow where interest party can file an opposition. If no opposition is filed, the patent letter will be sealed and granted.  New Zealand is the second marked to approve the patent since Singapore’s approval in March earlier this year. As the nicotine patent is based on the plattform patent that Nicoccino AB uses through licensing, the protection of the

Skanska builds new premises in Huddinge at Karolinska University Hospital for about SEK 1.2 billion

Skanska has signed a contract with Locum for a new hospital building at the Karolinska University Hospital in Huddinge, Sweden. The contract is worth SEK 1.2 billion, which will be included in order bookings for Skanska Sweden for the third quarter in 2016.The project's gross floor area is about 29,000 square meters and the building will house about 23 operating rooms and sterilization center, about 8 rooms for interventional services, about 21 rooms for X-ray examinations and related support areas. Skanska, Locum and the Stockholm County Council has ambitious climate targets for the

Update on the Consumer transaction

Oslo, 3 October 2016Reference is made to the stock exchange announcements made on 18 July and 16 August 2016 regarding the share purchase agreement entered into on 17 July 2016 between Opera Software ASA ("Opera") and Golden Brick Capital Private Equity Fund I L.P. (the “Buyer”) on the sale and purchase of Opera's consumer business (the "Transaction").The regulatory review by CFIUS is still ongoing. The parties agree that the required part of the reorganization that is to take place prior to closing was completed by September 30, hence pursuant to the amendment agreement No.1 to the

Telia Company signs a EUR 1,500 million revolving credit facility

Telia Company has signed a new dual tranche EUR 1,500 million Revolving Credit Facility with a group of thirteen relationship banks. The Facility has a tenor of 5 years and includes two extension options of one year each, at the approval of the lenders. This facility will replace the existing EUR 1,000 million credit facility dated December 20, 2010, and EUR 1,000 million credit facility dated June 9, 2014, ensuring full eligibility by its extended maturity under the rating agencies’ liquidity models.Bank of America Merrill Lynch, Barclays, BNP Paribas, Citi and Danske Bank acted as co-

Axel Johnson International acquires French steel wire rope and lifting equipment distributor Traction Levage

With the acquisition of Traction Levage, Axel Johnson International further strengthens the market position for its lifting, anchoring and cargo securing business in southern Europe.Traction Levage will become part of Axel Johnson International’s business group AxLoad, specialists in steel wire ropes, lifting and cargo securing solutions for industry. Over the last decade, strong organic growth has been combined with a number of strategic acquisitions and today the business group has annual sales of 370 MEUR and operations in 15 countries throughout Europe. “Traction Levage will provide

Acting CEO appointed

Techstep ASA (the “Company”) hereby announces that the termination notice period for its Chief Executive Officer, Lonnie Schilling, has expired and, as a result, that Mr. Schilling no longer serves as CEO of the Company. The Company wishes to express its gratitude to Mr. Schilling for his contribution over the years. By resolution of the Board of Directors of the Company, Fredrik Johansson, Chief Operating Officer and acting Chief Financial Officer, has assumed the position as acting Chief Executive Officer, pending the Board’s decision on a permanent Chief Executive Officer. In

Orkla acquires attractive gut health brand in Poland

Orkla has, through its wholly owned subsidiary Orkla Health Poland, signed and completed an agreement to acquire the brand Colon-C through an asset transaction. With this acquisition, Orkla is strengthening its foothold in the rapidly growing gut health category. Colon-C is a leading brand in the constipation category and a strong market leader in the fibre segment in Poland. By acquiring Colon-C, Orkla expands its platform in gut health, which already consists of the brands Husk and Samarin. "The acquisition of Colon-C is strategically important for strengthening Orkla Health's

Joacim Sjöberg assumes his position as Executive Vice President in Hemfosa Fastigheter as of today

Today, Joacim Sjöberg assumes his position as a new Senior Executive within Hemfosa Fastigheter AB, the Board of Directors has appointed him Executive Vice President and he will be part of the Company’s Executive Management Team.This appointment is a step in the Company's efforts to strengthen its Executive Management Team and ensure long-term, controlled succession planning following the departure of CEO Jens Engwall, who, provided approval of the Board, intends to hand over operational control of the Company to Joacim Sjöberg prior to the end of 2017. Joacim Sjöberg most recently

Skanska invests in land in Warsaw, Poland, for EUR 22M, about SEK 200M

Skanska acquires about 5,000 square meters of land in Warsaw, Poland. The total investment amounts to EUR 22M, about SEK 200M.The land plot is located at 7/9 Łucka Street in Warsaw’s Wola district, one of the most rapidly developing parts of the city, and is planned for future office development. The estimated gross leasable potential is about 35,000 square meters and the plot is situated in proximity to other Skanska’s projects – Generation Park, Atrium 1 and Atrium 2. Skanska Commercial Development Europe initiates and develops office property projects. The company’s operations are

Catella financial advisor in the establishment of Solnaberg Property

275 clients of Catella Bank and its partner have subscribed for shares in a newly formed company, Solnaberg Property AB, which has in turn acquired the Bladet 3 property from CapMan Real Estate. The property is situated in attractive location in Solna, Stockholm, and consists of a total of 31,325 square metres of offices and a parking garage, with If Skadeförsäkring as its largest tenant. Torbjörn Wiberg has been appointed CEO of Solnaberg Property, which is eventually planned to be listed on Nasdaq First North.Catella’s corporate finance department acted as financial advisor in the

Final outcome of the 2016 Capital Joint Decision and Probability of Default (PD) inspection

Nordea has on 30 September received the final Capital Joint Decision. The expected Common Equity Tier 1 ratio requirement by 30 September is 17.3%. The Common Equity Tier 1 requirement of 17.3% includes 85 bp (equivalent to a Common Equity Tier 1 requirement of EUR ~1.2bn and a total Own funds requirement of EUR ~1.5bn) due to the PD inspection performed by the college of supervisors (FSAs) during 2016 as well as the corporate risk weight memo (FI Ref. 15-13020). Nordea takes note of the SFSA combined assessment related to the PD inspection and the corporate risk weight memo (FI Ref.

Selvaag Bolig ASA - good sales and more homes under construction

Selvaag Bolig sold 277 homes with a total value of NOK 1.13 billion during the third quarter of 2016. The company had 1 464 units under construction at 30 September. "Our products are well received by the market, and due to substantial sales we have initiated the construction of 223 homes," comments CEO Baard Schumann. "We take a positive view of future market developments, and are offering new residential properties for sale as quickly as we can. Demand in Greater Oslo is particularly high because of urbanisation and insufficient housing construction. The market in the Stavanger area

Charlotte Mecklenburg Library cardholders have free access to Tutor.com

With a Charlotte Mecklenburg Library card in hand, students of all ages can access live, one-to-one help from professional tutors online – for free – through Tutor.com . Tutor.com  is accessible from home, school or the Library. Help is available for K-12 students, college students and adult learners – in both English and Spanish.  Through the Library’s website, cardholders have access to Tutor.com 

There are no items matching the current filter
There are no more items matching the current filter
Back to top